Sterling Biotech`s (STERLINBIO) principal activity is to manufacture and sell gelatin and di-calcium phosphate. It is a major operating division of the diversified Sandesara group of companies. The company installed capacities producing 10,400 MPTA of gelatin. The plant located at Baroda has been set up in strategic alliance with Croda International of the UK, a leading multinational and the largest producer of proteins in the world. The gelatins manufactured by the company are used in the pharmaceutical industry in hard and soft shell capsules, vitamin encapsulation, tablet binding and plasma expander in addition to application in food and photographic industries. Sterling Biotech is the largest manufacturer of pharmaceutical gelatin in Asia. Sterling Biotech currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatins. It has more than 70% market share in India. Since manufacture of gelatin is an energy intensive process, Sterling has DG sets producing 8 MW uninterrupted power supply.
You
should Trade Less But Trade Accurately & this is Achieved with our Tip.
